Based on the Real-World Results From Australia, Immunotherapy Is Not a Good Option for Patients With Mesothelioma

被引:4
|
作者
Gray, Steven G. [1 ]
Meirson, Tomer [2 ]
Mutti, Luciano [3 ,4 ]
机构
[1] St James Hosp, Trinity St Jamess Canc Inst, Thorac Oncol Res Grp, Dublin, Ireland
[2] Beilinson Med Ctr, Davidoff Canc Ctr, Rabin Med Ctr, Petah Tiqwa, Israel
[3] Univ Aquila, Dept Biotechnol & Appl Clin Sci, Coppito Bldg,Second Floor Via Vetorio SNC, I-67100 Laquila, Italy
[4] Temple Univ, Coll Sci & Technol, Ctr Biotechnol, Sbarro Hlth Res Org, Philadelphia, PA USA
关键词
MALIGNANT PLEURAL MESOTHELIOMA; THORACIC ONCOLOGY PLATFORM; CHEMOTHERAPY; PEMBROLIZUMAB;
D O I
10.1016/j.jtho.2024.01.016
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:541 / 546
页数:6
相关论文
共 50 条
  • [41] Toxicities from immunotherapy: From clinical trials to real-world clinical practice
    Riveiro-Barciela, Mar
    Trallero-Araguas, Ernesto
    Martinez-Valle, Fernando
    MEDICINA CLINICA, 2020, 155 (12): : 541 - 547
  • [42] Real-world evidence of the impact of immunotherapy (IT) on overall survival (OS) of patients (p) with malignant pleural mesothelioma (MPM) adjusted for tumor histology
    Cedres Perez, S. M.
    Valdivia, A. A.
    Assaf Pastrana, J. D.
    Iranzo Gomez, P.
    Callejo Perez, A.
    Pardo Aranda, N.
    Navarro Mendivil, A. F.
    Martinez-Marti, A.
    Priano, I.
    Ucha Hermida, J. M.
    Garcia-Galea, E.
    Gonzalo, J.
    Caro, R.
    Carbonell, C.
    Amat, R.
    Dienstmann, R.
    Felip, E.
    ANNALS OF ONCOLOGY, 2023, 34 : S1134 - S1134
  • [43] Peanut Oral Immunotherapy: Data from a Real-World Clinical Practice
    Wang, Julie
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2019, 7 (02): : 427 - 428
  • [44] REAL-WORLD EVIDENCE OF OPTION VALUE IN METASTATIC MELANOMA
    Wong, W.
    To, T. M.
    Li, M.
    Lee, W.
    Veenstra, D.
    Garrison, L. P.
    VALUE IN HEALTH, 2021, 24 : S239 - S239
  • [45] REAL-WORLD CIM - NETWORKING IS AN ESSENTIAL COMPETITIVE OPTION
    SNELLER, JA
    MODERN PLASTICS, 1985, 62 (11): : 49 - 53
  • [46] Real-world evidence for option value in metastatic melanoma
    Wong, William B.
    To, Tu My
    Li, Meng
    Lee, Woojung
    Veenstra, David L.
    Garrison, Louis P., Jr.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2021, 27 (11): : 1546 - 1555
  • [47] Real-world use of systemic therapy in elderly patients with malignant pleural mesothelioma (MPM)
    Cedres, S.
    Assaf, J. D.
    Iranzo, P.
    Callejo, A.
    Pardo, N.
    Navarro, A.
    Martinez-Marti, A.
    Rodriguez, G.
    Monton, V.
    Gonzalo, J.
    Miquel, J. M.
    Pedrola, A.
    Dienstmann, R.
    Felip, E.
    ANNALS OF ONCOLOGY, 2019, 30
  • [48] Real-World Use of Therapeutic Anticoagulation in Patients with Paroxysmal Nocturnal Hemoglobinuria. Results of a Survey of Physicians in Australia
    Szer, Jeffrey
    Forsyth, Cecily J.
    Giese, Anja
    BLOOD, 2015, 126 (23)
  • [49] Real-World Data of Nivolumab and Pembrolizumab in Chemotherapy Pre-Treated Mesothelioma Patients
    Dumoulin, D.
    Cantini, L.
    Belderbos, R.
    Mercieca, D.
    Cornelissen, R.
    Aerts, J.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S267 - S267
  • [50] HOSPITALIZATIONS IN HYPERCHYLOMICRONEMIA PATIENTS IN QUEBEC, CANADA; RESULTS FROM A REAL-WORLD OBSERVATIONAL STUDY
    Lachaine, J.
    Gaudet, D.
    Miron, A.
    Tremblay, K.
    VALUE IN HEALTH, 2015, 18 (07) : A679 - A679